老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Taysha Gene Therapies, Inc.

5.76
+0.20003.60%
成交量：161.31万
成交额：917.26万
市值：15.78亿
市盈率：-17.15
高：5.81
开：5.57
低：5.46
收：5.56
52周最高：5.81
52周最低：1.05
股本：2.74亿
流通股本：1.84亿
量比：0.88
换手率：0.88%
股息：- -
股息率：- -
每股收益(TTM):-0.3359
每股收益(LYR):-0.3570
净资产收益率：-64.93%
总资产收益率：-25.70%
市净率：7.20
市盈率(LYR):-16.13

数据加载中...

总览公司新闻资讯公告
2020/12/17

重要事件披露

8-K - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/24

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/11/05

重要事件披露

8-K - Current report
2020/11/04

重要事件披露

8-K - Current report
2020/10/27

重要事件披露

8-K - Current report
2020/10/14

重要事件披露

8-K - Current report
2020/10/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/07

重要事件披露

8-K - Current report
2020/10/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/29

重要事件披露

8-K - Current report
2020/09/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/17

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/17

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多